Suite of reports to facilitate safe use of Anticoagulants.
Accessing the Population Reporting Searches:
To access the CDRC Anticoagulation Population Reporting Searches on EMIS, you will need to download and import the following .zip file:
As the operator of the CDRC, Health Innovation North East and North Cumbria Limited (on behalf of itself and/or its licensors) grants you a licence to copy and download this document in accordance with our terms of use. You must not modify the content of this document in any way, and you must not use any illustrations, photographs, video or audio sequences or any graphics separately from any accompanying text. For further details, please see our terms of use (Terms of use – Clinical Digital Resource Collaborative (cdrc.nhs.uk)
If you have not performed this process before, please refer to the Download/ Import guide below, which provides you with step-by-step instructions on how to Download and Import .zip files into EMIS:
You can check whether you have the most up-to-date version by reviewing the date on the .zip file. Any updates to the Population Reporting searches will be communicated to CDRC Precision users via the mailing list for the CDRC. To ensure you stay up to date with the latest information, please sign up to the mailing list at http://eepurl.com/9131L
Guidance on the Population Reporting Searches:
Primary searches in this folder are pre-fixed with an ‘?’, making it easier to locate and run these searches.
| Report Name | Returns | Action |
| ? Anticoagulation Safety 01 – ?Poor Concordance | Patients with repeat anticoagulants who have not had a recent issue within 3 months (NB will ‘incorrectly’ detect people who have recently started treatment in secondary care and not had first primary care issue) | Review patient and discuss concordance if appropriate |
| ? Anticoagulation Safety 02 – DOAC – Antiphospholipid Syndrome – consider stopping | Patients on a DOAC with antiphospholipid syndrome EMA Warning ** | Review the patient and consider stopping/switching to VKA |
| ? Anticoagulation Safety 03.0 – DOAC – Consider Reduced Dose – hard reasons | Patients on DOAC who may need a reduced dose due to factors such as age, weight, eGFR, interacting medication – based on the medicine summary of product characteristics | Review the patient and consider DOAC dose |
| ? Anticoagulation Safety 03.01 – DOAC – Consider Reduced Dose – hard reasons – AF only | As above but only for patients with AF. | Review the patient and consider DOAC dose |
| ? Anticoagulation Safety 04 – DOAC – Severe renal impairment – consider stopping | Patients on DOAC with renal function below the recommended lower safe limit | Review the patient and consider DOAC safety |
| ? Anticoagulation Safety 05 – DOAC – No apparent indication | Patients on DOAC without clear indication | Review the patient and consider suitability of DOAC or add indication as appropriate |
| ? Anticoagulation Safety 05.1 – DOAC – No apparent licensed indication | Patients on DOAC without clear licensed indication – NB that the DOACs are only licensed for the AF indication when certain risk factors are present. | Review the patient and consider suitability of DOAC or add indication as appropriate |
| ? Anticoagulation Safety 06 – DOAC – Contraindicated/not recommended drugs | Patients on DOAC with a contraindicated/not recommended concomitant medication | Review the patient using the anticoagulation template and consider DOAC safety |
| ? Anticoagulation Safety 07 – DOAC – Consider Dose Increase | Patients on DOAC who may need a dose increase. 7.21 – Based on SmPC licensed criteria but excluding those with >=2 soft criteria for reduced dose | Coding may be inaccurate or consider dose increase |
| ? Anticoagulation Safety 08.1 – DOAC – Cockroft Gault CrCl Record Overdue – tests done | Patients on a DOAC who don’t have a recording of Cockroft Gault creatinine clearance within a relevant time period (depending on their renal function) 8.1 – Test done report – renal function checked but CG not calculated | Either: Use the anticoagulation template to record CG CrCl based on last eGFR OR Call patient for U+E if not done in relevant time period. |
| ? Anticoagulation Safety 08.2 – DOAC – Cockroft Gault CrCl Record Overdue – tests not done | As above but tests not done | Consider blood test |
| ? Anticoagulation Safety 09 – DOAC – High GI Bleed Risk | Patients that have a high GI bleed risk | |
| 09 DOAC – High GI bleeding risk – No gastroprotection | Patients in the report above who are not on gastroprotection | Consider need for gastroprotection |
| ? Anticoagulation Safety 10 – Warfarin or VKA – No INR in the last 12w # | Patients on vitamin K antagonist with no INR record in the last 12 weeks | Check/record INR |
| ? Anticoagulation Safety 11 – Warfarin or VKA – No TTR in the last year # | Patients on vitamin K antagonist with no INR record in the last 12 weeks | Record TTR |
| ? Anticoagulation Safety 12 – Warfarin or VKA – Latest TTR <65% # | Patients on vitamin K antagonist whose latest recorded TTR is <65% | Review the patient and consider vit K antagonist safety +/- update TTR |
| ? Anticoagulation Safety 13 – Warfarin or VKA – Poor control (NICE criteria) # | Patients on vitamin K antagonist with poor control according to NICE criteria | Review the patient and consider vit K antagonist safety |
| ? Anticoagulation Safety 14 – Duplicate Anticoagulant # | Patients on more than one anticoagulant | Consider stopping one |
| ? Anticoagulation Safety 15 – DOAC and heart valve (unspecified) | Any valve which isn’t specified as tissue | Review record. Stop DOAC if mechanical heart valve or replace non-specific heart valve code with tissue heart valve. |
| ? Anticoagulation Safety 15 – DOAC and heart valve (mechanical) | Any mechanical valve | As above |